David Haase MD: Regenerative Plasma

Alzheimer’s disease represents a multi-system failure rather than a singular condition, requiring a shift from symptom-focused treatment to personalized, systems-based medicine. Dr. David Haase, founder of the Maxwell Clinic, emphasizes that cognitive decline is often preceded by decades of systemic dysfunction, including metabolic, vascular, and inflammatory issues. Regenerative plasma exchange (RPE) emerges as a transformative intervention, functioning by removing toxic, oxidized plasma and replacing it with purified albumin to act as an antioxidant sponge. Clinical data, such as the AMBAR trial, demonstrate that this process can significantly slow, and in some cases reverse, neurodegenerative progression. Beyond specialized therapies, achieving longevity and brain health necessitates a comprehensive approach, integrating rigorous lifestyle changes, early neurocognitive screening, and a commitment to self-care as essential components for maintaining long-term vitality and cognitive function.